Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 4/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.36 |
| ▸ | TACR2 | P21452 | 3/20 | 0.35 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.34 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26558457 | 0.86 | CYP2C9 (0.40) | CYP2C19CYP2C9ALDH1A1CYP3A4MAPT | |
| SCHEMBL26242360 | 0.86 | CYP2C9 (0.40) | CYP2C19CYP2C9ALDH1A1CYP3A4MAPT | |
| SCHEMBL26557795 | 0.86 | CYP2C9 (0.40) | CYP2C19CYP2C9ALDH1A1CYP3A4MAPT | |
| SCHEMBL26557802 | 0.80 | CYP2C9 (0.40) | CYP2C19CYP2C9ALDH1A1CYP3A4MAPT | |
| SCHEMBL26037732 | 0.77 | LGALS8 (0.43) | ALDH1A1CYP3A4TDP1MAPK1L3MBTL1 | |
| SCHEMBL26037726 | 0.77 | LGALS8 (0.43) | ALDH1A1CYP3A4TDP1MAPK1L3MBTL1 | |
| SCHEMBL26242260 | 0.76 | ALDH1A1 (0.38) | CYP2C19CYP2C9ALDH1A1CYP3A4MAPT | |
| SCHEMBL26566191 | 0.75 | CYP2C19 (0.40) | CYP2C19CYP2C9ALDH1A1CYP3A4MAPT | |
| SCHEMBL26566231 | 0.75 | CYP2C19 (0.40) | CYP2C19CYP2C9ALDH1A1CYP3A4MAPT | |
| SCHEMBL26565783 | 0.74 | ALDH1A1 (0.38) | CYP2C19CYP2C9ALDH1A1CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331751-A1 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331751-A1 | STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES | NUDT1, PNP, ATIC | CYP2C19 1262/4885CYP2C9 906/4885ALDH1A1 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.